Jan Kroon
My research focuses on the development of novel glucocorticoid receptor-targeting therapeutics for metabolic diseases like Cushing’s syndrome and nonalcoholic fatty liver disease. Our preclinical findings have identified several lead compounds with various glucocorticoid receptor modulating properties, and have progressed to clinical evaluation.
